Florbetaben F18

DRUG3 trials

Sponsors

Columbia University, University of Chicago, Lantheus Germany GmbH

Conditions

AgingAlzheimer DiseaseCardiac AmyloidosisDementiaPrimary Progressive AphasiaWhite Matter Hyperintensities

Phase 1

Test-retest Study With [18F]FBB in Cardiac Amyloidosis

RecruitingNCT06790394

Lantheus Germany GmbHCardiac Amyloidosis

Start: 2025-10-21End: 2026-09-01Target: 15Updated: 2026-08-03

Unknown Phase

Brain Vascular Disease in Aging and Dementia

CompletedNCT03075007

Columbia UniversityAging, Alzheimer Disease, Dementia +1

Start: 2017-05-23End: 2019-08-31Updated: 2019-09-12

Florbetaben PET Imaging in PPA

CompletedNCT04720001

University of ChicagoAlzheimer Disease, Primary Progressive Aphasia

Start: 2018-08-23End: 2021-02-26Updated: 2024-10-16